Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 2
1946 3
1947 5
1948 2
1949 1
1950 8
1951 7
1952 9
1953 14
1954 6
1955 20
1956 22
1957 21
1958 19
1959 18
1960 36
1961 26
1962 32
1963 41
1964 367
1965 501
1966 669
1967 953
1968 973
1969 1118
1970 1128
1971 1208
1972 1275
1973 1375
1974 1420
1975 1341
1976 1271
1977 1232
1978 1354
1979 1252
1980 1027
1981 512
1982 203
1983 161
1984 213
1985 261
1986 295
1987 337
1988 341
1989 443
1990 482
1991 541
1992 575
1993 567
1994 776
1995 734
1996 849
1997 744
1998 834
1999 891
2000 913
2001 890
2002 903
2003 982
2004 968
2005 1093
2006 1190
2007 1184
2008 1227
2009 1243
2010 1401
2011 1460
2012 1441
2013 1447
2014 1218
2015 1248
2016 1354
2017 1414
2018 1390
2019 655
2020 26
Text availability
Article attribute
Article type
Publication date

Search Results

49,379 results
Results by year
Filters applied: . Clear all
Page 1
[Autologous stem cell transplantation in systemic sclerosis].
Henes JC, et al. Z Rheumatol 2016 - Review. PMID 27510996 German.
Autologous hematopoietic stem cell transplantation (HSCT) is a very effective treatment option for patients with severe systemic sclerosis (SSc). ...Further improvement of transplantation regimens as well as a better understanding of the underlying pathogenetic principles and mechanisms of action should be the aim of further studies on HSCT....
Autologous hematopoietic stem cell transplantation (HSCT) is a very effective treatment option for patients with severe system
Safety of Autologous Human Schwann Cell Transplantation in Subacute Thoracic Spinal Cord Injury.
Anderson KD, et al. J Neurotrauma 2017 - Clinical Trial. PMID 28225648
The rationale for implantation of autologous human Schwann cells (SCs) in persons with subacute spinal cord injury (SCI) is based on evidence that transplanted SCs are neuroprotective, support local axonal plasticity, and are capable of myelinating axons. A Phase I clinical trial was conducted to evaluate the safety of autologous human SC transplantation into the injury epicenter of six subjects with subacute SCI. ...
The rationale for implantation of autologous human Schwann cells (SCs) in persons with subacute spinal cord injury (SCI) is based on …
[Autologous hematopoietic stem cell transplantation in systemic lupus erythematosus].
Alexander T, et al. Z Rheumatol 2016 - Review. PMID 27612476 German.
For these patients autologous hematopoietic stem cell transplantation (ASCT) after immunoablative chemotherapy provides a promising treatment option with curative potential. ...By careful patient selection and improved anti-infection prophylaxis during stem cell therapy, transplantation-associated mortality could be reduced from an initial 13 % to currently an average of 6 %. ...
For these patients autologous hematopoietic stem cell transplantation (ASCT) after immunoablative chemotherapy provides a prom …
Clinical benefits of autologous haematopoietic stem cell transplantation in type 1 diabetes patients.
Gu B, et al. Diabetes Metab 2018 - Clinical Trial. PMID 29331269
The present study aimed to evaluate the safety and clinical efficacy of autologous haematopoietic stem cell transplantation (AHSCT) in adolescent patients with newly diagnosed T1D. ...Most of the adverse events in the AHSCT group were transplantation complications. Our data suggest that AHSCT treatment was well tolerated and slowed deterioration of islet β-cell function while significantly decreasing daily insulin dosages. ...
The present study aimed to evaluate the safety and clinical efficacy of autologous haematopoietic stem cell transplantation (A …
Autologous osteochondral transplantation for osteochondral lesions of the talus in an athletic population.
Fraser EJ, et al. Knee Surg Sports Traumatol Arthrosc 2016. PMID 25962962
PURPOSE: To assess clinical outcomes and return to sport in an athletic population treated with autologous osteochondral transplantation (AOT) for osteochondral lesions of the talus. ...All patients underwent autologous osteochondral transplantation of the talus under the care of a single surgeon. At a mean follow-up of 5.9 years, patients were assessed using the American Orthopaedic Foot and Ankle Society (AOFAS) scoring system. ...
PURPOSE: To assess clinical outcomes and return to sport in an athletic population treated with autologous osteochondral transplan
The role of autologous haemopoietic stem cell transplantation in the treatment of autoimmune disorders.
Rebeiro P and Moore J. Intern Med J 2016 - Review. PMID 26524106
Autologous haemopoietic stem cell transplantation (HSCT) has been used for over 30 years for malignant haematological diseases, such as myeloma and lymphoma, with considerable success. ...Two randomised control trials have confirmed that HSCT is superior to monthly cyclophosphamide in systemic sclerosis with a highly significant disease free and overall survival benefit demonstrated in the Autologous Stem cell Transplantation International Scleroderma trial. ...
Autologous haemopoietic stem cell transplantation (HSCT) has been used for over 30 years for malignant haematological diseases
[Autologous stem cell transplantation for autoimmune diseases: recommendations from the SFGM-TC].
Farge D, et al. Pathol Biol (Paris) 2014. PMID 25017794 French.
Autologous hematopoietic stem cell transplantation is a valid alternative to immunosuppressive treatment in patients with auto-immune disease; however, the role of this approach remains subject to debate. ...In this article we give an overview regarding the indications of autologous stem cell transplantation in auto-immune diseases as well as recommendations regarding post-transplant follow-up of patients....
Autologous hematopoietic stem cell transplantation is a valid alternative to immunosuppressive treatment in patients with auto
Autologous transplantation of adipose-derived stem cells improves functional recovery of skeletal muscle without direct participation in new myofiber formation.
Gorecka A, et al. Stem Cell Res Ther 2018. PMID 30016973 Free PMC article.
The aim of this study was to evaluate the effect of ADSC transplantation on functional skeletal muscle regeneration in an acute injury model. ...However, the ADSC-injected muscles had improved contractility in comparison with the collagen-injected controls 28 days post-transplantation. ...
The aim of this study was to evaluate the effect of ADSC transplantation on functional skeletal muscle regeneration in an acute injur …
Autologous bone marrow transplantation for the treatment of multiple sclerosis.
Radaelli M, et al. Curr Neurol Neurosci Rep 2014 - Review. PMID 25037718
In the last decade, owing to the growing experience in selecting the most appropriate patients to transplant and the recent advances in chemotherapeutic and support regimens, the transplant-related mortality of autologous HSCT in MS patients dropped down to 1,3 % and the progression-free survival ranges from 47 % to 100 %. Altogether, these data support autologous HSCT as a possible second-line therapy for refractory MS....
In the last decade, owing to the growing experience in selecting the most appropriate patients to transplant and the recent advances …
Fat Grafting: A Growing Problem?
Lambros V. Plast Reconstr Surg 2018. PMID 29370005
49,379 results
Jump to page
Feedback